Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biochem Mol Biol Educ ; 50(1): 149-157, 2022 01.
Artículo en Inglés | MEDLINE | ID: mdl-34878214

RESUMEN

Project-based (research-driven) laboratory courses stimulate student involvement, improve critical thinking and initiate cooperative learning. To this end, a 7-week laboratory project was designed for a sophomore cell biology course to reinforce the fundamental relationship between genotype and phenotype using yeast alcohol dehydrogenase I (ADH1). Working in pairs, students used site-directed mutagenesis to create a H44R mutation in the ADH1 gene sequence inserted into a YEp13 shuttle vector. These plasmids were propagated in E. coli, sequenced, and reintroduced into a yeast strain expressing no ADH1 activity. The growth patterns on selective media were determined. As the mutation allows for growth in the presence of allyl alcohol, students make the connection between DNA sequence and protein function. Student performance was assessed with pre- and post-tests, with improvement observed across all learning objectives. In addition to meeting the learning outcomes, 98% of the students thought that this experience allowed them to see how the scientific process can encompass multiple techniques to answer a single question. Eighty-four percent of the students thought that this experience was more engaging than other lab experiences they have had. Our multi-week laboratory examining the phenotypic changes in yeast alcohol metabolism successfully developed students' understanding of the scientific process, knowledge of molecular techniques and the relationship of gene sequence to protein function in an engaging manner.


Asunto(s)
Alcohol Deshidrogenasa , Saccharomyces cerevisiae , Alcohol Deshidrogenasa/genética , Escherichia coli , Genotipo , Humanos , Fenotipo , Proteínas , Saccharomyces cerevisiae/genética
2.
Int J Med Mushrooms ; 20(12): 1173-1183, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30806298

RESUMEN

Ganoderma lucidum, a mushroom that has been used to treat disease in East Asia for centuries, has been shown to be effective against many types of tumors, but the exact cellular mechanism of action is unknown. In this study we examined proliferation of a lung cancer cell line after treatment with 12 concentrations of powdered G. lucidum for 24, 48, and 120 hours. Based on half-maximal inhibitory concentrations values, proliferation of the H1793 cell line seemed to be sensitive to the extract in a time- and dose-dependent manner. We used immunoblot analysis to examine the amounts of cell cycle proteins (cyclin D, Cdk4, and Cdc2) and apoptotic proteins (Bcl-xL and Bax) after treatment with a range of G. lucidum concentrations. Changes in amounts of proteins that regulate the cell cycle were consistent with longer G1 and G2 phases. Proapoptotic protein (Bax) levels increased 6.5-fold, with a commensurate increase in the Bax-to-Bcl ratio, especially at 48 and 120 hours. These results suggest that the decrease in cellular proliferation correlated with a change in both cell cycle progression and apoptosis, and that the triterpenoid in G. lucidum is the bioactive component. Further biochemical characterization of this ancient herbal remedy could hold promise for treating lung cancer.


Asunto(s)
Proliferación Celular/efectos de los fármacos , Neoplasias Pulmonares/fisiopatología , Extractos Vegetales/farmacología , Reishi/química , Triterpenos/farmacología , Apoptosis/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Quinasa 4 Dependiente de la Ciclina/genética , Quinasa 4 Dependiente de la Ciclina/metabolismo , Humanos , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/metabolismo , Extractos Vegetales/química , Triterpenos/química , Proteína X Asociada a bcl-2/genética , Proteína X Asociada a bcl-2/metabolismo
3.
Toxicol Sci ; 152(1): 62-71, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-27071941

RESUMEN

Epidemiological evidence indicates that cadmium and arsenic exposure increase lung cancer risk. Cadmium and arsenic are environmental contaminants that act as endocrine disruptors (EDs) by activating estrogen receptors (ERs) in breast and other cancer cell lines but their activity as EDs in lung cancer is untested. Here, we examined the effect of cadmium chloride (CdCl2) and sodium arsenite (NaAsO2) on the proliferation of human lung adenocarcinoma cell lines. Results demonstrated that both CdCl2 and NaAsO2 stimulated cell proliferation at environmentally relevant nM concentrations in a similar manner to 17ß-estradiol (E2) in H1793, H2073, and H1944 cells but not in H1792 or H1299 cells. Further studies in H1793 cells showed that 100 nM CdCl2 and NaAsO2 rapidly stimulated mitogen-activated protein kinase (MAPK, extracellular-signal-regulated kinases) phosphorylation with a peak detected at 15 min. Inhibitor studies suggest that rapid MAPK phosphorylation by NaAsO2, CdCl2, and E2 involves ER, Src, epidermal growth factor receptor, and G-protein coupled ER (GPER) in a pertussis toxin-sensitive pathway. CdCl2 and E2 activation of MAPK may also involve ERß. This study supports the involvement of membrane ER and GPER signaling in mediating cellular responses to environmentally relevant nM concentrations of CdCl2 and NaAsO2 in lung adenocarcinoma cells.


Asunto(s)
Adenocarcinoma/enzimología , Arsenitos/toxicidad , Cloruro de Cadmio/toxicidad , Membrana Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Disruptores Endocrinos/toxicidad , Receptor beta de Estrógeno/agonistas , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Neoplasias Pulmonares/enzimología , Receptores de Estrógenos/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Transducción de Señal/efectos de los fármacos , Compuestos de Sodio/toxicidad , Adenocarcinoma/patología , Adenocarcinoma del Pulmón , Línea Celular Tumoral , Membrana Celular/metabolismo , Relación Dosis-Respuesta a Droga , Activación Enzimática , Receptores ErbB/metabolismo , Receptor beta de Estrógeno/metabolismo , Humanos , Neoplasias Pulmonares/patología , Fosforilación , Factores de Tiempo , Familia-src Quinasas/metabolismo
4.
J Affect Disord ; 123(1-3): 303-7, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19880188

RESUMEN

BACKGROUND: There are numerous reports of abnormalities in the expression of the sodium- and potassium-activated adenosine triphosphatase (Na,K-ATPase) in response to an ionic stress with ethacrynic acid (ECA) challenge in bipolar subjects. However, all of these studies have been in out-bred populations. In an attempt to reduce the genetic variability associated with this observation, we examined this phenomenon within an isolated breeding population. METHODS: We studied 36 lymphoblastoid cell lines obtained from Old Order Amish individuals who had bipolar disorder, type I (16), or were unaffected siblings of the same gender (9) or unrelated normal controls(11). Cells were treated with 10(-)(5)M ECA for 3 days after which Na,K-ATPase alpha1 protein expression and activity ([(3)H]-ouabain binding, (86)Rb-uptake, and intracellular sodium and potassium concentrations) were measured. RESULTS: Cells from bipolar patients expressed less Na,K-ATPase as measured by immunoblot analysis after ECA treatment (0.94 + or - SD 0.13 relative units) compared to unaffected siblings (1.06 + or - 0.12, P = 0.029) and Old Order Amish normal controls (1.06 + or - 0.14, P = 0.0004). None of the other variables studied were different. LIMITATIONS: This is a study of peripheral cells which do not express all of the Na,K-ATPase expressed in the brain. The observed difference is small. CONCLUSIONS: Ethacrynic-acid-stimulated lymphoblast sodium pump expression in Old Order Amish bipolar subjects is reduced compared to Amish controls.


Asunto(s)
Trastorno Bipolar/genética , Trastorno Bipolar/fisiopatología , Inhibidores Enzimáticos/farmacología , Ácido Etacrínico/farmacología , Etnicidad/genética , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Western Blotting , Línea Celular , Femenino , Humanos , Linfocitos/efectos de los fármacos , Linfocitos/metabolismo , Masculino , Persona de Mediana Edad , Ouabaína/metabolismo , Potasio/metabolismo , Sodio/metabolismo
5.
Prog Neuropsychopharmacol Biol Psychiatry ; 30(7): 1261-4, 2006 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-16815616

RESUMEN

PURPOSE: Intracerebroventricular (ICV) administration of ouabain, a potent sodium pump inhibitor, has been used to model mania. Antipsychotic agents have demonstrated efficacy in the management of acute mania. This study was undertaken to determine the prophylactic efficacy of olanzapine and haloperidol in the ouabain mania model. METHODS: Male Sprague-Dawley rats (4-8/group) were treated with two haloperidol decanoate intramuscular shots one week apart (21 mg/kg) or twice daily olanzapine intraperitoneal injections at low dose (1 mg/kg/day) or high dose (6 mg/kg/day) for 7 days prior to ICV administration of ouabain. Open field locomotion was quantified at baseline and after ouabain administration. RESULTS: Ouabain caused a significant increase in open field locomotion (253.7+/-SEM 55.12 vs control 53.1+/-12.13 squares traversed in 30 min in the olanzapine experiments, P<0.05; and 236.5+/-41.42 vs 129.3+/-38.23, P<0.05 in the haloperidol experiments). Olanzapine alone at low dose (102.2+/-37.7) or high dose (151.2+/-49.2) did not alter open field activity. Low dose olanzapine (176.6+/-73.27) but not high dose (307.5+/-167.32) caused a modest reduction of the ouabain effect. Haloperidol alone significantly reduced motoric activity compared to control (55.6+/-18.0, P<0.05), and prevented ouabain-induced hyperactivity (60.3+/-33.1, P<0.05). CONCLUSION: Haloperidol, but not olanzapine, demonstrated efficacy in this mania model, but methodological details may have reduced the effect of olanzapine.


Asunto(s)
Antipsicóticos/uso terapéutico , Trastorno Bipolar/tratamiento farmacológico , Haloperidol/uso terapéutico , Análisis de Varianza , Animales , Conducta Animal/efectos de los fármacos , Benzodiazepinas/uso terapéutico , Modelos Animales de Enfermedad , Evaluación de Medicamentos , Interacciones Farmacológicas , Inhibidores Enzimáticos/uso terapéutico , Conducta Exploratoria/efectos de los fármacos , Masculino , Olanzapina , Ouabaína/uso terapéutico , Ratas , Ratas Sprague-Dawley
6.
Endocr Relat Cancer ; 13(1): 113-34, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16601283

RESUMEN

The higher frequency of lung adenocarcinoma in women smokers than in men smokers suggests a role for gender-dependent factors in the etiology of lung cancer. We evaluated estrogen receptor (ER) alpha and beta expression and activity in human lung adenocarcinoma cell lines and normal lung fibroblasts. Full-length ERalpha and ERbeta proteins were expressed in all cell lines with higher ERbeta than ERalpha. Although estradiol (E(2)) binding was similar, E(2) stimulated proliferation only in cells from females, and this response was inhibited by anti-estrogens 4-hydroxytamoxifen (4-OHT) and ICI 182,780. In contrast, E(2) did not stimulate replication of lung adenocarcinoma cells from males and 4-OHT or ICI did not block cell proliferation. Similarly, transcription of an estrogen response element-driven reporter gene was stimulated by E(2) in lung adenocarcinoma cells from females, but not males. Progesterone receptor (PR) expression was increased by E(2) in two out of five adenocarcinoma cell lines from females, but none from males. E(2) decreased E-cadherin protein expression in some of the cell lines from females, as it did in MCF-7 breast cancer cells, but not in the cell lines from males. Thus, ERalpha and ERbeta expression does not correlate with the effect of ER ligands on cellular activities in lung adenocarcinoma cells. On the other hand, coactivator DRIP205 expression was higher in lung adenocarcinoma cells from females versus males and higher in adenocarcinoma cells than in normal human bronchial epithelial cells. DRIP205 and other ER coregulators may contribute to differences in estrogen responsiveness between lung adenocarcinoma cells in females and males.


Asunto(s)
Adenocarcinoma/metabolismo , Receptor alfa de Estrógeno/metabolismo , Receptor beta de Estrógeno/metabolismo , Neoplasias Pulmonares/metabolismo , Adenocarcinoma/patología , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Bronquios/citología , Bronquios/efectos de los fármacos , Bronquios/metabolismo , Cadherinas/metabolismo , Proliferación Celular/efectos de los fármacos , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Estradiol/farmacología , Moduladores de los Receptores de Estrógeno/farmacología , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Humanos , Pulmón/citología , Pulmón/efectos de los fármacos , Pulmón/metabolismo , Neoplasias Pulmonares/patología , Subunidad 1 del Complejo Mediador , Receptores Activados del Proliferador del Peroxisoma/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptores de Progesterona/metabolismo , Elementos de Respuesta , Sexo , Factores de Transcripción/metabolismo , Transcripción Genética , Células Tumorales Cultivadas
7.
Bipolar Disord ; 5(5): 362-5, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-14525557

RESUMEN

BACKGROUND: Human bipolar illness is characterized by mood state- and diagnosis-associated abnormalities of cellular cation distribution and transport. These include reduced sodium pump activity and expression and increased intracellular sodium. If these alterations are related to the pathophysiology of the disease, rather than secondary or ancillary abnormalities, then one would expect that modeling of these changes in vivo would produce lithium-preventable behavioral abnormalities. METHODS: Ouabain, a potent inhibitor of the sodium pump, was administered intracerebroventricularly to male rats previously fed lithium-containing food or plain rat chow. Locomotion was then quantified in an open field. RESULTS: Ouabain increased locomotion 300% over baseline. Lithium pretreatment prevented the ouabain-induced hyperlocomotion response. CONCLUSION: Inhibition of central nervous system sodium pump with ouabain produces a plausible animal model of mania. This model may be useful for preclinical screening of potential mood stabilizers.


Asunto(s)
Trastorno Bipolar/tratamiento farmacológico , Inhibidores Enzimáticos/uso terapéutico , Ouabaína/uso terapéutico , Animales , Modelos Animales de Enfermedad , Vías de Administración de Medicamentos , Interacciones Farmacológicas , Inhibidores Enzimáticos/administración & dosificación , Inyecciones Intraventriculares , Litio/sangre , Litio/uso terapéutico , Locomoción/efectos de los fármacos , Masculino , Ouabaína/administración & dosificación , Ratas , Ratas Sprague-Dawley , Factores de Tiempo
8.
Bipolar Disord ; 5(2): 123-8, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12680902

RESUMEN

BACKGROUND: Ethacrynic acid (ECA), a diuretic that has several cellular actions, increases expression of the sodium and potassium-activated adenosine triphosphatase (Na, K-ATPase or Na pump) in normal lymphocytes, but not in lymphocytes of bipolar patients. While this has been proposed to be important in the pathophysiology of bipolar illness, the response of neural tissues to ECA is unknown. METHODS: Human neuroblastoma SH-SY5Y cells differentiated with 10-microM retinoic acid were treated with various ECA concentrations for 3 days, and changes in Na-pump alpha-isoform expression were quantified with densitometric analysis of Western bands. RESULTS: Expression of alpha1 and alpha3 Na pump isoforms significantly increased with 10-5 M ECA. Cells treated with 10-6 or 10-7 M ECA showed no change in Na-pump expression, while cells treated with 10-4 M ECA died. The alpha2 isoform could not be detected in differentiated SH-SY5Y cells. CONCLUSIONS: The effect of ECA on alpha1-isoform in neural tissue is similar to that observed in lymphocytes. As alpha3 isoform is not expressed in lymphocytes, however, we conclude that lymphocytes are an incomplete model of neural tissue.


Asunto(s)
Neoplasias Encefálicas/enzimología , Neoplasias Encefálicas/patología , Diuréticos/efectos adversos , Ácido Etacrínico/farmacología , Isoenzimas/metabolismo , Neuroblastoma/enzimología , Neuroblastoma/patología , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Trastorno Bipolar/enzimología , Trastorno Bipolar/fisiopatología , Western Blotting , Ácido Etacrínico/análisis , Humanos , Immunoblotting , Transporte Iónico/efectos de los fármacos , Linfocitos/metabolismo , Espectrometría de Fluorescencia , Factores de Tiempo , Células Tumorales Cultivadas
9.
Bipolar Disord ; 4(3): 201-6, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12180275

RESUMEN

BACKGROUND: The pathophysiology of manic-depression may be associated with dysregulation of ion homeostasis. Ouabain is a potent inhibitor of the sodium-potassium adenosine triphosphatase and has been purported to mimic abnormalities seen in acute mania. As manic episodes are believed to be neurotoxic and mood stabilizers have recently been implicated as neuroprotectants, it is of interest to determine if lithium and valproic acid antagonize ouabain-induced neurotoxicity. METHODS: Human neuroblastoma SH-SY5Y cells were differentiated for 12 days then pretreated with lithium or valproic acid for 24 h and then challenged with a 10 microM ouabain insult. Cellular damage was assessed with lactate dehydrogenase (LDH) release, and apoptotic potential of ouabain was evaluated with DNA fragmentation. RESULTS: Ouabain significantly increased LDH release after 72 h of treatment. Lithium pretreatment at 1 mM diminished ouabain-induced LDH release. Valproic acid alone at 100 and 1000 micrograms/mL significantly increased LDH release from the cells. Furthermore, it significantly potentiated ouabain-induced LDH release. DNA fragmentation suggests that ouabain induces apoptosis. CONCLUSIONS: Lithium at the therapeutic level of 1 mM limits the extent of cellular damage caused by 10 microM ouabain in SH-SY5Y cells as measured by LDH release. Valproic acid alone at the therapeutic concentration of 100 micrograms/mL induces LDH release and does not prevent ouabain-induced LDH release.


Asunto(s)
Antimaníacos/farmacología , Apoptosis/efectos de los fármacos , Litio/farmacología , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Ouabaína/toxicidad , Ácido Valproico/farmacología , Fragmentación del ADN/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Humanos , L-Lactato Deshidrogenasa/metabolismo , Neuroblastoma , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...